Goldman Sachs Adjusts PT on Thermo Fisher Scientific to $610 From $650, Maintains Buy Rating

Endpoints NewsLilly obesity meds Foundayo and Zepbound to gain CVS coverage

BioPharma DiveGSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’

Endpoints NewsFor wearables, it’s a GLP-1 world

BioPharma DiveCVS obesity drug deal puts Lilly on equal footing with Novo

FierceBiotechIcon ends internal accounting investigation, finds it overstated revenue in prior years

FierceBiotechFDA extends Beren’s rare disease review after info request, further stretching saga

BioWorldBreakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections

Endpoints NewsICON audit finds overstated revenue; Secretome and Psilera raise cash

Endpoints News#ASCO26: After leaving Legend, Frank Fan is ready to showcase his next project

FierceBiotechHoth Therapeutics’ pivot to AI in space sees stock rocket after rebrand

CellFarnesylation-driven KRAS phase separation promotes colon tumor growth

CellStructural basis of Wnt signalosome extracellular complex assembly